Equity
€2.6m ▲ 21.6%
PHI-BIS has made a profit without a break since 2019.
PHI-BIS
Lifetime
14 annual accounts with figures on one time axispeak €16.2m (2025)
€16.2m▲ 7.5%
lowest -€201,106 (2018)
€462,055▼ 10.4%
peak €2.6m (2025)
€2.6m▲ 21.6%
€3.6m▲ 14.7%
peak 50.7 FTE (2020)
41 FTE▼ 4.7%
Board11 names since 2019
1 directorColisée Belgium
Owners7 names in the annual accountsall names
99.75%ARMONEA and 2 others
Documentsfilings and deeds
16-07-202615 days before the deadline
2025financial year
Equity from €2.1m to €2.6mCash from €7,574 to €10,317
Key points
from the 2025 annual accountsGrowth
4 years
4 years of growth in a row. Turnover 2025: €16.2m.
Investments
€7,803 0.1 × depreciation
Green is investment, beige is depreciation.
Staff
40 employees on 31-12-2025
In 2025, 40 people joined and 43 left. On top of that, 0.5 agency workers worked there on average.
Filings
14 annual accounts since 2012
The last five annual accounts were filed 13 to 35 days before the end of the period.
Position in the sector
€462,055
Higher net result than 87% of companies in retail trade. Sector median €39,909 · 5,068 companies.
Checked score
85
Excellent
Financially stronger than 52% of small companies in retail trade (NACE 47)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.4% across 3,697 companies (NACE 47, small).
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.5%
01-2025: 0.5%● unchanged vs 12-2024
02-2025: 0.4%▼ -0.1 percentage points vs 01-2025
03-2025: 0.4%● unchanged vs 02-2025
04-2025: 0.5%▲ +0.1 percentage points vs 03-2025
05-2025: 0.5%● unchanged vs 04-2025
06-2025: 0.5%● unchanged vs 05-2025
07-2025: 0.7%▲ +0.2 percentage points vs 06-2025highest value
08-2025: 0.4%▼ -0.3 percentage points vs 07-2025
09-2025: 0.4%● unchanged vs 08-2025
10-2025: 0.4%● unchanged vs 09-2025
11-2025: 0.4%● unchanged vs 10-2025
12-2025: 0.4%● unchanged vs 11-2025
01-2026: 0.4%● unchanged vs 12-2025
02-2026: 0.4%● unchanged vs 01-2026
03-2026: 0.4%● unchanged vs 02-2026
04-2026: 0.4%● unchanged vs 03-2026
05-2026: 0.4%● unchanged vs 04-2026
06-2026: 0.4%● unchanged vs 05-2026
07-2026: 0.5%▲ +0.1 percentage points vs 06-2026
08-2026: 0.4%▼ -0.1 percentage points vs 07-2026
09-2026: 0.3%▼ -0.1 percentage points vs 08-2026
10-2026: 0.3%● unchanged vs 09-2026
11-2026: 0.3%● unchanged vs 10-2026lowest value
Financial strengthAverage
Score breakdown
raises risk
Liquidity: current ratio 1.35, cash €10,317
lowers risk
Founded in 2011
Figures for financial year 2025 (filed on 16-07-2026)
Profit of €462,055 (financial year 2025)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small). It does better than 63% of them on solvency, 18% on liquidity, 48% on profitability and 76% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 17,811 companies had the same profile as PHI-BIS has now. Each dot stands for 45 companies, two years later.
96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
That fits the bankruptcy probability of PHI-BIS itself: 0.3% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,811 companies, not a prediction for PHI-BIS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €220,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.35 (1.23 in 2024), below the usual 1.5. Short-term debt is 58.2% and cash 0.2% of total assets. 58.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
15 days early
2024
13 days early
2023
35 days early
2022
21 days early
2021
24 days early
2020
12 days early
2019
18 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 20 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- ARMONEA 99.75%score 53equity -€12.3m (2025) · annual accounts 2025
- Colisée Care SAS consolidatesannual accounts 2025
- RESTEL FLATS 0.25%score 87equity €19.1m (2025) · annual accounts 2025
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0835500392
Reappointment: EY Bedrijfsrevisoren BV (statutory auditor)
Permanent representative: Christophe Beckers · General meeting of 30-06-2026 · Gazette deed
Permanent representatives: Yves Remy and Guido Perremans
Board meeting of 22-08-2024 · Gazette deed
Permanent representative: Guido Perremans
Board meeting of 02-04-2024 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| PHI-BIS Malle | €16.2m | 4.7% | 41.8% | 41 |
| PHARMACIE HOUBA Brussels | €21.2m | 9.0% | 49.0% | 39.8 |
| MEDACTA BELGIUM Nivelles | €24.0m | 4.0% | 27.9% | 45.2 |
| FARMAZORG Oudenburg | €19.5m | 1.1% | 35.6% | 76.5 |
| PEETERS PHARMA Kinrooi | €37.3m | 4.1% | 20.9% | 54.9 |
| OXYCURE Fernelmont | €13.8m | 2.0% | 21.6% | 60.1 |
| Les Pharmaciens Associés Anderlecht | €16.9m | -2.4% | -98.3% | 17.6 |
Grey: the largest companies of the sector (retail trade (NACE 47)), without their names. Blue: the sector peers from the table.
These companies have the same main activity as PHI-BIS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €4.8m and €12m, founded between 1998 and 2010.
Official details
Source: KBO- Status
- Active since 12-04-2011Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 2 others
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.024.612.2092390 Malle, since 01-04-1984
- Financial year end
- 31 December
- Peppol
- Reachable since 29-10-2026
Annual accounts 2025
- €6.2m▲ 17.5%
- Employeeson 31-12-2025
- 40▼ 7.0%
- Filing
- Filed on 16-07-2026, 15 days before the end of the filing period
Insights on PHI-BIS
PHI-BIS has existed since 2011. Turnover grew from €146,500 in 2012 to €16.2m in 2025.
Turnover has grown every year since 2021.
ARMONEA holds all the shares. In February 2022, the Official Gazette published the appointment of MAN IN MOTION as managing director.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PHI-BIS
- What is the company number of PHI-BIS?
- The company number of PHI-BIS is 0835.500.392. The VAT number is the same number with BE in front: BE 0835.500.392.
- Where is PHI-BIS based?
- The registered office is at Hoogstraatsebaan 9, 2390 Malle.Company details
- What does PHI-BIS do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of PHI-BIS?
- PHI-BIS is a private limited company (BV).
- When was PHI-BIS founded?
- PHI-BIS was founded on 12-04-2011.
- Is PHI-BIS still active?
- Yes, PHI-BIS is an active enterprise in the KBO register.
- How many employees does PHI-BIS have?
- PHI-BIS had an average of 41 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does PHI-BIS fall under?
- In its 2025 annual accounts, PHI-BIS states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of PHI-BIS?
- The turnover of PHI-BIS was €16.2m in financial year 2025, according to the filed annual accounts.
- Is PHI-BIS profitable?
- In financial year 2025, PHI-BIS made a profit of €462,055.
- Where can I find the annual accounts of PHI-BIS?
- PHI-BIS filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHI-BIS due?
- PHI-BIS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies
See how customers, suppliers and banks see your own company and what to improve first.